UK government told relaxing COVID rules at Christmas will cost lives
By Estelle Shirbon LONDON (Reuters) - The British government came under intense pressure on Tuesday to revise its plan to relax COVID-19 restrictions for five days around Christmas, with two influential medical journals making a rare joint appeal for the policy to be scrapped.
By Estelle Shirbon
LONDON (Reuters) - The British government came under intense pressure on Tuesday to revise its plan to relax COVID-19 restrictions for five days around Christmas, with two influential medical journals making a rare joint appeal for the policy to be scrapped.
The leader of the main opposition Labour Party joined a chorus of politicians also calling on the government to change course as a surge of infections led to London being moved up into the strictest level of a tiered COVID restrictions system.
In what was only their second joint editorial in more than 100 years, the British Medical Journal and the Health Service Journal said the government should be tightening the rules rather than allowing three households to mix over five days.
"We believe the government is about to blunder into another major error that will cost many lives," the editorial said.
It argued that Britain should be following the more cautious examples of Germany, Italy and the Netherlands which have just announced they were tightening restrictions.
Britain has recorded 64,402 deaths from COVID, the second highest number in Europe.
Labour leader Keir Starmer urged Prime Minister Boris Johnson to urgently convene a meeting of the government's COBRA emergency response committee, and said he would support any decision to toughen up restrictions at Christmas.
"I understand that people want to spend time with their families after this awful year, but the situation has clearly taken a turn for the worse since the decision about Christmas was taken. It serves no one for politicians to ignore this fact," Starmer said.
The mayor of London, Labour's Sadiq Khan, also said the government should look again at its Christmas plans.
So far, it has deflected such calls by stressing the need for citizens to act responsibly.
"We must all ensure that we are careful and responsible over the Christmas period," Johnson's spokesman said.
"We've always said that Christmas this year will not be normal but we wanted to ensure that families and friends have the option to meet up in a limited and cautious way should they wish."
In their joint editorial, the two journals said that unless there was a change of policy the National Health Service (NHS) would face a stark choice after Christmas: stop most elective and non-urgent work or become overwhelmed by COVID patients.
"The main impact of a further surge in COVID-19 inpatients is likely to be felt most by those with other conditions," the editorial said.
(Additional reporting by Elizabeth Piper; editing by Michael Holden and Angus MacSwan)
This story has not been edited by Firstpost staff and is generated by auto-feed.
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
By Uday Sampath Kumar (Reuters) - Target Corp reported a 17.2% rise in comparable sales for the holiday season on Wednesday as its online sales more than doubled, thanks to faster deliveries and higher demand for home goods, electronics and beauty products.
By Medha Singh and Devik Jain (Reuters) - The S&P 500 and the Nasdaq rose in choppy trading on Wednesday as Intel shares jumped thanks to a change in management while broader sentiment was muted after a recent run to record highs. Intel said it would replace Chief Executive Officer Bob Swan with VMware Inc CEO Pat Gelsinger next month
By Danny Ramos LA PAZ (Reuters) - The Bolivian government said on Wednesday it had signed a contract with India's Serum Institute for the supply of 5 million doses of AstraZeneca's COVID-19 vaccine. President Luis Arce said that combined with a recent deal to buy 5.2 million Sputnik V vaccine doses from Russia, Bolivia now expected to be able to inoculate all of its vaccinable population. Both vaccines require two doses to be given, meaning they would be used to inoculate a total of 5.1 million people from Bolivia's 11.51 million-strong population.